Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.08 USD | +1.57% | -5.93% | -14.96% |
Apr. 22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
Mar. 28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |